BACKGROUND & AIMS: Statins can reduce biliary cholesterol secretion independently of their ability to inhibit cholesterol synthesis. Statins also prevent the formation of gallstones in animal studies, although the effect of statins on human gallstone disease has been controversial. METHODS: We examined the relationship between the use of statins and the risk of cholecystectomy in a cohort of US women. As part of the prospective Nurses' Health Study, participants biennially reported their history of gallstone disease and whether they had undergone cholecystectomy. Women also reported lifetime use of statins retrospectively in 2000. We conducted a retrospective analysis of statin using data collected in 2000, to define use from 1994 forward, and a prospective analysis for general lipid-lowering drugs from 1994 to 2004. RESULTS: In the statin analysis we ascertained 2479 cases of cholecystectomy during 305,197 person-years of follow-up evaluation. The multivariate relative risk for current statin users, compared with nonusers, was 0.82 (95% confidence interval, 0.70-0.96). In the analysis of general cholesterol-lowering drugs, we ascertained 3420 cases of cholecystectomy during 511,411 person-years of follow-up evaluation. Compared with nonusers, the multivariate relative risk for current users of general cholesterol-lowering drugs, mostly statins in this cohort, was 0.88 (95% confidence interval, 0.79-0.98). CONCLUSIONS: Statin use appears to reduce the risk of cholecystectomy in women.
BACKGROUND & AIMS: Statins can reduce biliary cholesterol secretion independently of their ability to inhibit cholesterol synthesis. Statins also prevent the formation of gallstones in animal studies, although the effect of statins on humangallstone disease has been controversial. METHODS: We examined the relationship between the use of statins and the risk of cholecystectomy in a cohort of US women. As part of the prospective Nurses' Health Study, participants biennially reported their history of gallstone disease and whether they had undergone cholecystectomy. Women also reported lifetime use of statins retrospectively in 2000. We conducted a retrospective analysis of statin using data collected in 2000, to define use from 1994 forward, and a prospective analysis for general lipid-lowering drugs from 1994 to 2004. RESULTS: In the statin analysis we ascertained 2479 cases of cholecystectomy during 305,197 person-years of follow-up evaluation. The multivariate relative risk for current statin users, compared with nonusers, was 0.82 (95% confidence interval, 0.70-0.96). In the analysis of general cholesterol-lowering drugs, we ascertained 3420 cases of cholecystectomy during 511,411 person-years of follow-up evaluation. Compared with nonusers, the multivariate relative risk for current users of general cholesterol-lowering drugs, mostly statins in this cohort, was 0.88 (95% confidence interval, 0.79-0.98). CONCLUSIONS: Statin use appears to reduce the risk of cholecystectomy in women.
Authors: M F Leitzmann; E B Rimm; W C Willett; D Spiegelman; F Grodstein; M J Stampfer; G A Colditz; E Giovannucci Journal: N Engl J Med Date: 1999-09-09 Impact factor: 91.245
Authors: R N Lemaitre; C D Furberg; A B Newman; S B Hulley; D J Gordon; J S Gottdiener; R H McDonald; B M Psaty Journal: Arch Intern Med Date: 1998-09-14
Authors: Jenny N Poynter; Stephen B Gruber; Peter D R Higgins; Ronit Almog; Joseph D Bonner; Hedy S Rennert; Marcelo Low; Joel K Greenson; Gad Rennert Journal: N Engl J Med Date: 2005-05-26 Impact factor: 91.245
Authors: S Tazuma; G Yamashita; H Ochi; H Miura; T Kajihara; Y Hattori; H Miyake; T Nishioka; H Hyogo; Y Sunami; S Yasumiba; G Kajiyama Journal: Clin Ther Date: 1998 May-Jun Impact factor: 3.393
Authors: Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa Journal: Gastroenterol Clin North Am Date: 2010-06 Impact factor: 3.806
Authors: Tsuyoshi Hamada; Natalia Khalaf; Chen Yuan; Ana Babic; Vicente Morales-Oyarvide; Zhi Rong Qian; Jonathan Andrew Nowak; Kimmie Ng; Peter Kraft; Douglas Adam Rubinson; Meir Jonathan Stampfer; Edward Luciano Giovannucci; Charles Stewart Fuchs; Shuji Ogino; Brian Matthew Wolpin Journal: J Gastroenterol Date: 2018-01-23 Impact factor: 7.527
Authors: Helen H Wang; Piero Portincasa; Ornella de Bari; Kristina J Liu; Gabriella Garruti; Brent A Neuschwander-Tetri; David Q-H Wang Journal: Eur J Clin Invest Date: 2013-02-19 Impact factor: 4.686
Authors: Pirjo Käkelä; Ville Männistö; Imre Ilves; Maija Vaittinen; Milla-Maria Tauriainen; Matti Eskelinen; Helena Gylling; Hannu Paajanen; Jussi Pihlajamäki Journal: Obes Surg Date: 2017-05 Impact factor: 4.129
Authors: Jung Eun Lee; Yoshifumi Baba; Kimmie Ng; Edward Giovannucci; Charles S Fuchs; Shuji Ogino; Andrew T Chan Journal: Cancer Prev Res (Phila) Date: 2011-06-16
Authors: Zhiwei Liu; Rotana Alsaggaf; Katherine A McGlynn; Lesley A Anderson; Huei-Ting Tsai; Bin Zhu; Yue Zhu; Sam M Mbulaiteye; Shahinaz M Gadalla; Jill Koshiol Journal: Gut Date: 2018-11-17 Impact factor: 23.059
Authors: Tsuyoshi Hamada; Natalia Khalaf; Chen Yuan; Vicente Morales-Oyarvide; Ana Babic; Jonathan A Nowak; Zhi Rong Qian; Kimmie Ng; Douglas A Rubinson; Peter Kraft; Edward L Giovannucci; Meir J Stampfer; Charles S Fuchs; Shuji Ogino; Brian M Wolpin Journal: Clin Gastroenterol Hepatol Date: 2018-02-21 Impact factor: 11.382